[ad_1]
It seems that well being care spending as a share of GDP has leveled off. Whereas reaching shut to twenty% of GDP in the course of the pandemic, 2022 had well being care spending (17.3% of GDP) extra according to pre-pandemic norms. Hartman et al. (2023) studies:
Well being care spending within the US grew 4.1 % to achieve $4.5 trillion in 2022, which was nonetheless a sooner fee of development than the rise of three.2 % in 2021 however was a lot slower than the speed of 10.6 % seen in 2020. In 2022, sturdy Medicaid and personal medical insurance spending development, together with a turnaround within the web price of insurance coverage, was considerably offset by continued declines in federal spending related to the COVID-19 pandemic. The insured share of the inhabitants reached a historic excessive of 92.0 % in 2022 as enrollment in non-public medical insurance elevated at a sooner fee relative to 2021 and Medicaid enrollment continued to expertise sturdy development. The share of the economic system accounted for by the well being sector was 17.3 % in 2022, which was down from a peak of 19.5 % in 2020 however was extra in keeping with the common share of 17.5 % throughout 2016–19.
Pharmaceutical spending as a share of whole well being care spending has been comparatively fixed at round 9% all through the previous 7 years.
You may learn extra fascinating statistics within the full article right here.
[ad_2]
